Muscle-specific SIRT1 gain-of-function increases slow-twitch fibers and ameliorates pathophysiology in a mouse model of duchenne muscular dystrophy
- PMID: 25032964
- PMCID: PMC4102452
- DOI: 10.1371/journal.pgen.1004490
Muscle-specific SIRT1 gain-of-function increases slow-twitch fibers and ameliorates pathophysiology in a mouse model of duchenne muscular dystrophy
Abstract
SIRT1 is a metabolic sensor and regulator in various mammalian tissues and functions to counteract metabolic and age-related diseases. Here we generated and analyzed mice that express SIRT1 at high levels specifically in skeletal muscle. We show that SIRT1 transgenic muscle exhibits a fiber shift from fast-to-slow twitch, increased levels of PGC-1α, markers of oxidative metabolism and mitochondrial biogenesis, and decreased expression of the atrophy gene program. To examine whether increased activity of SIRT1 protects from muscular dystrophy, a muscle degenerative disease, we crossed SIRT1 muscle transgenic mice to mdx mice, a genetic model of Duchenne muscular dystrophy. SIRT1 overexpression in muscle reverses the phenotype of mdx mice, as determined by histology, creatine kinase release into the blood, and endurance in treadmill exercise. In addition, SIRT1 overexpression also results in increased levels of utrophin, a functional analogue of dystrophin, as well as increased expression of PGC-1α targets and neuromuscular junction genes. Based on these findings, we suggest that pharmacological interventions that activate SIRT1 in skeletal muscle might offer a new approach for treating muscle diseases.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4102452/bin/pgen.1004490.g001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4102452/bin/pgen.1004490.g002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4102452/bin/pgen.1004490.g003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4102452/bin/pgen.1004490.g004.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4102452/bin/pgen.1004490.g005.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4102452/bin/pgen.1004490.g006.gif)
![Figure 7](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4102452/bin/pgen.1004490.g007.gif)
Similar articles
-
Alterations of neuromuscular junctions in Duchenne muscular dystrophy.Neurosci Lett. 2020 Oct 15;737:135304. doi: 10.1016/j.neulet.2020.135304. Epub 2020 Aug 17. Neurosci Lett. 2020. PMID: 32818587 Free PMC article. Review.
-
Gene expression in mdx mouse muscle in relation to age and exercise: aberrant mechanical-metabolic coupling and implications for pre-clinical studies in Duchenne muscular dystrophy.Hum Mol Genet. 2014 Nov 1;23(21):5720-32. doi: 10.1093/hmg/ddu287. Epub 2014 Jun 10. Hum Mol Genet. 2014. PMID: 24916377
-
Resveratrol induces expression of the slow, oxidative phenotype in mdx mouse muscle together with enhanced activity of the SIRT1-PGC-1α axis.Am J Physiol Cell Physiol. 2014 Jul 1;307(1):C66-82. doi: 10.1152/ajpcell.00357.2013. Epub 2014 Apr 23. Am J Physiol Cell Physiol. 2014. PMID: 24760981 Free PMC article.
-
Resveratrol decreases inflammation and increases utrophin gene expression in the mdx mouse model of Duchenne muscular dystrophy.Clin Nutr. 2013 Feb;32(1):104-11. doi: 10.1016/j.clnu.2012.06.003. Epub 2012 Jul 12. Clin Nutr. 2013. PMID: 22795790
-
An attempt of gene therapy in Duchenne muscular dystrophy: overexpression of utrophin in transgenic mdx mice.Acta Neurol Belg. 2000 Sep;100(3):146-50. Acta Neurol Belg. 2000. PMID: 11098286 Review.
Cited by
-
Retention of stress susceptibility in the mdx mouse model of Duchenne muscular dystrophy after PGC-1α overexpression or ablation of IDO1 or CD38.Hum Mol Genet. 2024 Mar 20;33(7):594-611. doi: 10.1093/hmg/ddad206. Hum Mol Genet. 2024. PMID: 38181046
-
SIRT1 Controls Enteroendocrine Progenitor Cell Proliferation in High-Fat Diet-Fed Mice.Cell Mol Gastroenterol Hepatol. 2023;16(6):1040-1057. doi: 10.1016/j.jcmgh.2023.08.006. Epub 2023 Aug 19. Cell Mol Gastroenterol Hepatol. 2023. PMID: 37598893 Free PMC article.
-
Mitochondrial dysfunction: roles in skeletal muscle atrophy.J Transl Med. 2023 Jul 26;21(1):503. doi: 10.1186/s12967-023-04369-z. J Transl Med. 2023. PMID: 37495991 Free PMC article. Review.
-
Effect of hypobaric hypoxia on the fiber type transition of skeletal muscle: a synergistic therapy of exercise preconditioning with a nanocurcumin formulation.J Physiol Biochem. 2023 Aug;79(3):635-652. doi: 10.1007/s13105-023-00965-1. Epub 2023 May 6. J Physiol Biochem. 2023. PMID: 37147493
-
Histone Deacetylases: Molecular Mechanisms and Therapeutic Implications for Muscular Dystrophies.Int J Mol Sci. 2023 Feb 21;24(5):4306. doi: 10.3390/ijms24054306. Int J Mol Sci. 2023. PMID: 36901738 Free PMC article. Review.
References
-
- Bassel-Duby R, Olson EN (2006) Signaling pathways in skeletal muscle remodeling. Annu Rev Biochem 75: 19–37. - PubMed
-
- Booth FW, Thomason DB (1991) Molecular and cellular adaptation of muscle in response to exercise: perspectives of various models. Physiol Rev 71: 541–585. - PubMed
-
- Pette D, Staron RS (2001) Transitions of muscle fiber phenotypic profiles. Histochem Cell Biol 115: 359–372. - PubMed
-
- Berchtold MW, Brinkmeier H, Muntener M (2000) Calcium ion in skeletal muscle: its crucial role for muscle function, plasticity, and disease. Physiol Rev 80: 1215–1265. - PubMed
-
- Olson EN, Williams RS (2000) Remodeling muscles with calcineurin. Bioessays 22: 510–519. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases